Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174331 | SCV000225613 | uncertain significance | not provided | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852124 | SCV002180643 | uncertain significance | Bethlem myopathy 1A | 2021-08-12 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 194056). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL6A3 protein function. This variant has not been reported in the literature in individuals affected with COL6A3-related conditions. This variant is present in population databases (rs760532694, ExAC 0.006%). This sequence change replaces serine with leucine at codon 1895 of the COL6A3 protein (p.Ser1895Leu). The serine residue is moderately conserved and there is a large physicochemical difference between serine and leucine. |